March 27, 2018
Vifor Pharma wants to place its hyperkalaemia treatment in Japan through its partner, Zeria
Vifor Pharma Group has granted Japanese company Zeria Pharmaceutical exclusive rights to develop and commercialise Veltassa, its sodium-free potassium binder approved…